{"as_of":"2026-08-10T08:41:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:2adb1b95a2072c13a5e4b4711d7809e942ca03b88cdc3c6c1d6966e333a7ca0d","coverage":[{"denominator":98,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":98,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-08T20:18:10.067022Z","state":"measured"},{"denominator":100,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":100,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-10T06:31:04.303077+00:00","state":"measured"},{"denominator":2,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":2,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-05T20:46:50.282066Z","state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"arxiv_reference","source_observed_at":"2026-05-20T13:33:19.185960Z","state":"measured"}],"external_citation_measurements":[],"inbound":[{"citation":{"cited_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2502.05107","snapshot_observed_at":"2026-08-05T20:46:50.282066Z","title":"3dmolformer: A dual-channel framework for structure- based drug discovery","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2508.10075","last_updated":"2025-08-13T16:27:12Z","snapshot_observed_at":"2026-08-05T20:46:49.193471Z","submitted_at":"2025-08-13T16:27:12Z","title":"Teaching LLMs to Speak Spectroscopy","version":1},"reference_index":2021,"source":"pdf_text","source_observed_at":"2026-08-05T20:46:50.282066Z"},"links":{"cited_paper":"/paper/2502.05107","citing_paper":"/paper/2508.10075"},"observation_digest":"sha256:d0a902c0a8a3e89478e843f452e45a32a638543bb4084216827084d5f00eee56","observation_id":"edee1cf9-9482-4d0d-af25-3cd725c0d2c8","resolution":{"observed_at":"2026-08-05T20:46:50.282066Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"cited_work":{"arxiv_id":"2502.05107","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2502.05107","snapshot_observed_at":"2026-06-05T21:23:00.469572Z","title":"3dmolformer: A dual-channel framework for structure-based drug discovery.arXiv preprint arXiv:2502.05107, 2025a","venue":null,"work_id":"39b2f995-7a94-4590-9886-e3df4498fc26","year":null},"citing_paper":{"arxiv_id":"2605.17693","last_updated":"2026-05-17T23:21:24Z","snapshot_observed_at":"2026-08-02T07:03:49.160544Z","submitted_at":"2026-05-17T23:21:24Z","title":"Fine-tuning Pocket-Aware Diffusion Models via Denoising Policy Optimization","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-05-20T13:30:39.413079Z"},"links":{"cited_paper":"/paper/2502.05107","citing_paper":"/paper/2605.17693"},"observation_digest":"sha256:7dc0c9f17d3f276d1603f714960be963d42ad9d153af2045233006f0816f5200","observation_id":"5769c0fc-f20c-4912-b018-2933ca97e332","resolution":{"observed_at":"2026-05-20T13:33:19.187671Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}}],"links":{"evidence":"/evidence","html":"/paper/2502.05107/citation-record","integrity":"/paper/2502.05107/integrity","json":"/paper/2502.05107/citation-record.json","paper":"/paper/2502.05107"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.713770Z","title":"write newline","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":1,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.713770Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ec8195605bda1228ce9d08ff3ac33e8ff808bd3b610d3c75d4e0ca0992653c2f","observation_id":"cb4905a3-57a0-4074-97b9-d8ef266579a2","resolution":{"observed_at":"2026-08-08T20:18:09.713770Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.719484Z","title":"Accurate structure prediction of biomolecular interactions with alphafold 3","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":2,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.719484Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:83e8643ffe6656e23c18c96648946de4bc2bf6f55e8cdb1e68b25f06210b6f95","observation_id":"175415be-1ed1-4328-80c9-f563359d6ff1","resolution":{"observed_at":"2026-08-08T20:18:09.719484Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.723934Z","title":"Guiding deep molecular optimization with genetic exploration","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":3,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.723934Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b758053e17f0d8e5fdfb50c187f5a95cd2405e506e995a192feeae53efe39bbf","observation_id":"edb8bbf9-5717-4625-aaf6-edf06b42b52d","resolution":{"observed_at":"2026-08-08T20:18:09.723934Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2405.11769","last_updated":"2024-05-20T04:05:30Z","snapshot_observed_at":"2026-08-08T16:47:07.268581Z","submitted_at":"2024-05-20T04:05:30Z","title":"Uni-Mol Docking V2: Towards Realistic and Accurate Binding Pose Prediction","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2405.11769","snapshot_observed_at":"2026-08-08T20:18:09.728081Z","title":"Uni-mol docking v2: Towards realistic and accurate binding pose prediction","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":4,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.728081Z"},"links":{"cited_paper":"/paper/2405.11769","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4aa4bf825ce44a6aad61ba6a6030d5604541ddc37f511b9dd8fe2a1ab0c28747","observation_id":"7914e2fb-fee1-4203-83bc-24e01fb905cc","resolution":{"observed_at":"2026-08-08T20:18:09.728081Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.732301Z","title":"Fast, accurate, and reliable molecular docking with quickvina 2","venue":null,"work_id":null,"year":2015},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":5,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.732301Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ad8eb89ccc7351037d879da8c14c2d7999df2f684991e8b4a09a11426185ee68","observation_id":"291a1c23-0e6a-48cb-bfaa-f6de406f7e3c","resolution":{"observed_at":"2026-08-08T20:18:09.732301Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.736088Z","title":"Randomized smiles strings improve the quality of molecular generative models","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":6,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.736088Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9d261410724e95556ad8aa089456ee96c3d5bacc41a7b535362411d61fcfe845","observation_id":"84a79ba4-4014-4fc7-b53d-230ed3dd0ee0","resolution":{"observed_at":"2026-08-08T20:18:09.736088Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.739915Z","title":"Geometric deep learning on molecular representations","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":7,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.739915Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3a795e125c1abc49326f96763e4404d5c4536cceaddaa2bc50ee2b1b56dd0fb1","observation_id":"de7a1e2e-1604-4a21-a09c-a73e28c13d85","resolution":{"observed_at":"2026-08-08T20:18:09.739915Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.743673Z","title":"Accurate prediction of protein structures and interactions using a three-track neural network","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":8,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.743673Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:edf602f45752038f5943b2a6a6c30a3235e57028a06ed51e338ec04d00a4d761","observation_id":"f99b2367-86dc-4440-83bb-cd7a9ef8b88d","resolution":{"observed_at":"2026-08-08T20:18:09.743673Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.747136Z","title":"Molgpt: molecular generation using a transformer-decoder model","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":9,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.747136Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:50e4db3b921c2ac4fc83a8330bcf3f814182cd4aea54603145d5f042429028a4","observation_id":"16f5c86c-0247-4e54-aab4-2923c667e32b","resolution":{"observed_at":"2026-08-08T20:18:09.747136Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.750930Z","title":"Can ai reproduce observed chemical diversity? bioRxiv, pp.\\ 292177, 2018","venue":null,"work_id":null,"year":2018},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":10,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.750930Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:2aa287f3f52362fb3c4caf8c46c38dc61a032b2a98df51b1d1f2408c7a9440da","observation_id":"c5cfb648-aa2f-4cdf-a9d9-14e668b21a26","resolution":{"observed_at":"2026-08-08T20:18:09.750930Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.755531Z","title":"Quantifying the chemical beauty of drugs","venue":null,"work_id":null,"year":2012},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":11,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.755531Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:919eb406a4d0f2e3dfae4e5cd1ffe7c048f69838ecaa6476cc3e7c9a2bda1ae3","observation_id":"3a98d0e0-686d-48d9-bbc0-5a1f2ce727a2","resolution":{"observed_at":"2026-08-08T20:18:09.755531Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.758963Z","title":"The role of ai in drug discovery: challenges, opportunities, and strategies","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":12,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.758963Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:bd3532c5fdecea2b038bbca62ad734731976d473a5ac9f3ef4f78fcca3ca1a46","observation_id":"0195aa7c-c8ea-4b7e-bb52-a4f0b401f557","resolution":{"observed_at":"2026-08-08T20:18:09.758963Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.762353Z","title":"Language models are few-shot learners","venue":null,"work_id":null,"year":1901},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":13,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.762353Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:1aa627bc0ef8ea061bba20ff5eaae7cf72f3b133c094b8752e4f5e1e3a95e6ee","observation_id":"3c078ba4-f7c4-4f1c-8e4e-c1b301d9c225","resolution":{"observed_at":"2026-08-08T20:18:09.762353Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.765709Z","title":"Posebusters: Ai-based docking methods fail to generate physically valid poses or generalise to novel sequences","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":14,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.765709Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3fa9b9621d1ee7662b96fc8aecb109307ad2066c2815bbe0e7560415f846ddc8","observation_id":"da742913-4ced-458c-b99e-165ea6c30eb0","resolution":{"observed_at":"2026-08-08T20:18:09.765709Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.769045Z","title":"Structure-aware protein self-supervised learning","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":15,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.769045Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:12a58f1696d6842b4022c30aababa873422490768df4d3ae2aa06072c72a5fb2","observation_id":"c87fed1c-8b61-4ab7-ad91-095ec8bffd93","resolution":{"observed_at":"2026-08-08T20:18:09.769045Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.772461Z","title":"Diffdock: Diffusion steps, twists, and turns for molecular docking","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":16,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.772461Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:279ac8d3f44a7b8d0dddce3ca9663c1d4b2a1ac3d9575dddae68cba6f08ea936","observation_id":"f1900091-ff2a-4b90-bc04-ac9866934ade","resolution":{"observed_at":"2026-08-08T20:18:09.772461Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.775916Z","title":"Deep confident steps to new pockets: Strategies for docking generalization","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":17,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.775916Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f048a3f286ae53a9287d52cfd10903afa0ee78417f8564c12a591b5a109fbb36","observation_id":"cd4b59d1-9e2c-4c39-8b30-7b5a6c3a7471","resolution":{"observed_at":"2026-08-08T20:18:09.775916Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.779115Z","title":"BERT : Pre-training of deep bidirectional transformers for language understanding","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":18,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.779115Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:625183af6087f8b7d8ddf9f2ab93911bb8a557181847bb876872efe404f2c408","observation_id":"443602cc-6519-47ec-9936-0ff20e35dd0b","resolution":{"observed_at":"2026-08-08T20:18:09.779115Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.782596Z","title":"Chai-1: Decoding the molecular interactions of life","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":19,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.782596Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:6f33af5f06360ad11b0844da7848f83020ec2c9f19c570e29aad399a64fdccae","observation_id":"d4e31fac-3454-4608-8304-d998ac27c3dc","resolution":{"observed_at":"2026-08-08T20:18:09.782596Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2203.14500","last_updated":"2022-03-28T05:05:11Z","snapshot_observed_at":"2026-07-06T12:53:03.092529Z","submitted_at":"2022-03-28T05:05:11Z","title":"MolGenSurvey: A Systematic Survey in Machine Learning Models for Molecule Design","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2203.14500","snapshot_observed_at":"2026-08-08T20:18:09.785975Z","title":"Molgensurvey: A systematic survey in machine learning models for molecule design","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":20,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.785975Z"},"links":{"cited_paper":"/paper/2203.14500","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:0f42d61a4393b536bd6caa168896433c26bfc888c23793410909b5d8516c2fe5","observation_id":"114b6848-860b-4014-9f3f-96ab0b27213d","resolution":{"observed_at":"2026-08-08T20:18:09.785975Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.267636Z","title":"Machine learning-aided generative molecular design","venue":null,"work_id":"7a6a22a0-9660-460e-91d4-8ad48e9cc135","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":21,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.789739Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a67198f8c2e7c3a5c29f4ea4b96372fec2f541cc65b06421955eec24ec1a52ed","observation_id":"5d0b6881-c3a5-46de-83e9-7405230c43c9","resolution":{"observed_at":"2026-08-08T20:18:11.271444Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.257313Z","title":"Autodock vina 1.2","venue":null,"work_id":"d1859a96-39d6-4417-9916-b00c996b11ba","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":22,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.793066Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:24ccf10f6f0ce1800a859b40909b16c9a12c14fcf62a54d0ed5995360f6839b9","observation_id":"8de2f3fa-9b0c-465c-9d21-f1a5e693dbfc","resolution":{"observed_at":"2026-08-08T20:18:11.260891Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.246299Z","title":"Limo: Latent inceptionism for targeted molecule generation","venue":null,"work_id":"dd4f6639-7699-4a41-b24a-36c513106ca7","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":23,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.796377Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:78a473b2da3075f1f6cc9754c57976cd79e8fef53f503de90205653162bea493","observation_id":"86b82672-5fb3-4160-bd6a-9125f66bd37f","resolution":{"observed_at":"2026-08-08T20:18:11.249951Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.235604Z","title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","venue":null,"work_id":"8a48110f-2743-420a-940b-c6adee634d64","year":2009},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":24,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.799823Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ad20f56f94e8e36c7f8b1ab84a6ea26d2e3a781d7ab981d8b71fae18dae208f5","observation_id":"3d09dff8-68b6-4d4d-9cf2-16386eb4126b","resolution":{"observed_at":"2026-08-08T20:18:11.239402Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.224992Z","title":"Geometry-enhanced molecular representation learning for property prediction","venue":null,"work_id":"31bbd004-38e6-41b3-8762-97a31dd756d5","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":25,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.803086Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:c2e9118ae09fe65df8adca3dd0a7298eb09716a8be74b7b0023c9efa97c078fb","observation_id":"e45490cd-a86b-41c7-9911-c6dbdc365b16","resolution":{"observed_at":"2026-08-08T20:18:11.228695Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.214555Z","title":"Protein-ligand binding representation learning from fine-grained interactions","venue":null,"work_id":"544dec3f-5f7e-4539-9c98-323ddb953d7b","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":26,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.806888Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d93a55a33266f4d92101129b477873fb897804b8e298b838b9413854cbeaff43","observation_id":"5134fab5-8ca1-4602-85f3-e040d6bb4a16","resolution":{"observed_at":"2026-08-08T20:18:11.218329Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.204140Z","title":"Generation of 3d molecules in pockets via a language model","venue":null,"work_id":"0496baea-be14-48c1-9eda-61baf49ec6b2","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":27,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.810512Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3bc355d066b7a4226f3c8dae64016c4180a343dfc490b1cd64e1d247b191cbf6","observation_id":"c9a6661d-0ef0-42b6-a6b0-d1bdbe464486","resolution":{"observed_at":"2026-08-08T20:18:11.207899Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2305.05708","last_updated":"2023-05-09T18:35:38Z","snapshot_observed_at":"2026-07-06T15:25:16.703799Z","submitted_at":"2023-05-09T18:35:38Z","title":"Language models can generate molecules, materials, and protein binding sites directly in three dimensions as XYZ, CIF, and PDB files","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2305.05708","snapshot_observed_at":"2026-08-08T20:18:09.813832Z","title":"Language models can generate molecules, materials, and protein binding sites directly in three dimensions as xyz, cif, and pdb files","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":28,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.813832Z"},"links":{"cited_paper":"/paper/2305.05708","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:58e64778657c1f6ce44320b5cd69533d4f728fd98f92e83bd3f73271dacd66a1","observation_id":"167a9a6d-3db4-4bd0-82b4-31a7a5f1f8e1","resolution":{"observed_at":"2026-08-08T20:18:09.813832Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.194013Z","title":"Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design","venue":null,"work_id":"027cd0d4-82c2-4a1a-9453-6f0eeeeb686a","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":29,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.818243Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a0823dad22208315a42a01a0b2b55b412dadde43c61c17bbc708bebbe4634460","observation_id":"6f22fe68-be67-4218-b169-34709dff0ddc","resolution":{"observed_at":"2026-08-08T20:18:11.197712Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.184198Z","title":"Reinforced genetic algorithm for structure-based drug design","venue":null,"work_id":"a4b012bd-130b-4d86-b8e1-7333b921b729","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":30,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.821781Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:0f209a2fd08df66940c730f481d4f16ed86abbe20491e71eb7dce22eab050ae4","observation_id":"809debfa-a843-472c-b64f-a553d2b03b77","resolution":{"observed_at":"2026-08-08T20:18:11.187761Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.173724Z","title":"Drugclip: Contrasive protein-molecule representation learning for virtual screening","venue":null,"work_id":"caeae9a6-aab1-4b16-bd38-3b4ff771ad05","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":31,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.825199Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ceec7e80e8514f3b2941affb1c96542f356f6c3109a926dd58ea6bf9f838c2a4","observation_id":"3defdbf6-b430-439a-bad5-cf91c4e67438","resolution":{"observed_at":"2026-08-08T20:18:11.177401Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2403.12987","last_updated":"2024-03-04T07:40:25Z","snapshot_observed_at":"2026-07-06T17:47:13.814205Z","submitted_at":"2024-03-04T07:40:25Z","title":"Rethinking Specificity in SBDD: Leveraging Delta Score and Energy-Guided Diffusion","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2403.12987","snapshot_observed_at":"2026-08-08T20:18:09.829323Z","title":"Rethinking specificity in sbdd: Leveraging delta score and energy-guided diffusion","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":32,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.829323Z"},"links":{"cited_paper":"/paper/2403.12987","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b68fe44deb316737aaf9ec82e5f6803b7ff8ee4ef1860d2965cf6abe13250c5f","observation_id":"aaa7dcaa-b49a-4f28-b0cf-fb0ba077fe92","resolution":{"observed_at":"2026-08-08T20:18:09.829323Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2310.02989","last_updated":"2024-12-15T07:07:28Z","snapshot_observed_at":"2026-08-02T07:22:00.304892Z","submitted_at":"2023-10-04T17:26:16Z","title":"xVal: A Continuous Numerical Tokenization for Scientific Language Models","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2310.02989","snapshot_observed_at":"2026-08-08T20:18:09.833094Z","title":"xval: A continuous number encoding for large language models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":33,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.833094Z"},"links":{"cited_paper":"/paper/2310.02989","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:472258897dff1080c8ab2d317a69bf63383203798a507da8a422106055b820f3","observation_id":"c1b66612-293f-4725-a3a0-c623f770b23b","resolution":{"observed_at":"2026-08-08T20:18:09.833094Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.162985Z","title":"3d equivariant diffusion for target-aware molecule generation and affinity prediction","venue":null,"work_id":"ba961aa4-c64c-4fde-a0ed-74f391ff1754","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":34,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.836967Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4a6ff385e76238740ffc05a57c1ffc3ae37ccb935fc80703873cafc0cb048cfc","observation_id":"df18a194-d036-48bf-ab3b-a3710b7c5a16","resolution":{"observed_at":"2026-08-08T20:18:11.166691Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.152345Z","title":"Decompdiff: diffusion models with decomposed priors for structure-based drug design","venue":null,"work_id":"1bd0c90a-a1e5-41d9-ab25-24918a983dd6","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":35,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.840700Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:c1f4e8baee9583c866dafdb2ce63a6456c1293be40a12e332216dd90cf8d767a","observation_id":"97e8ce77-4deb-492e-b50c-f47ffc221689","resolution":{"observed_at":"2026-08-08T20:18:11.156261Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2308.07413","last_updated":"2023-08-14T19:01:21Z","snapshot_observed_at":"2026-07-06T16:06:10.797909Z","submitted_at":"2023-08-14T19:01:21Z","title":"Benchmarking Generated Poses: How Rational is Structure-based Drug Design with Generative Models?","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2308.07413","snapshot_observed_at":"2026-08-08T20:18:09.844205Z","title":"Benchmarking generated poses: How rational is structure-based drug design with generative models? arXiv preprint arXiv:2308.07413, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":36,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.844205Z"},"links":{"cited_paper":"/paper/2308.07413","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:59cf4d962f545bf208d0b32068e7842a2bb81e1e95e5008f2b13c9eb83b493a5","observation_id":"8fd3328e-c2fb-4094-ba7f-36942b62330d","resolution":{"observed_at":"2026-08-08T20:18:09.844205Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.141856Z","title":"De novo drug design using reinforcement learning with multiple gpt agents","venue":null,"work_id":"d2415303-6f7c-47cc-adbb-16bf908fe529","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":37,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.847898Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:73015e2f767f4e2ccea643e81f77c956de3a2ecd4e33a245f1d07762c42d98f7","observation_id":"ce79d82f-a64d-46c2-abb2-89b79b6272c5","resolution":{"observed_at":"2026-08-08T20:18:11.145441Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.131302Z","title":"Hamiltonian diversity: effectively measuring molecular diversity by shortest hamiltonian circuits","venue":null,"work_id":"1034a288-ad2f-4a4a-aff0-c9bf805b3181","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":38,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.851141Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fc80cacb01426c9ba5dec1d81318c150958cf6662ce1871d61f8e83643bcd84f","observation_id":"0dda3e0d-3089-4e27-ba80-19b0fc6892ce","resolution":{"observed_at":"2026-08-08T20:18:11.134943Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.118924Z","title":"Chemformer: a pre-trained transformer for computational chemistry","venue":null,"work_id":"072801a0-e5fa-4940-a02f-9e7deed68605","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":39,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.854507Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:00d4bf8e05e627fe51ef77ece6afbee0b7c06cae04e105216fdec9bde2c4620d","observation_id":"33866d9d-7d99-455e-a563-02d86b0f8e2d","resolution":{"observed_at":"2026-08-08T20:18:11.123516Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.107054Z","title":"Structure-based drug design with geometric deep learning","venue":null,"work_id":"cc02509c-a239-41bb-8e50-ec9a0c2fa845","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":40,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.857785Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:080fdd90fc341b452b67cbccd6a941d6acbb23d36a03ae7a20328a410885e0d6","observation_id":"1e8e51af-ebed-4a28-b6db-d670c9c6e887","resolution":{"observed_at":"2026-08-08T20:18:11.110962Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.095250Z","title":"Structure-based drug design with geometric deep learning","venue":null,"work_id":"1949994a-25cb-45cd-a641-828d8580ba4c","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":41,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.861275Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:99726c5de813037ab2d66cb95fc470a843f8a43574d4d637959ada9a70368ff5","observation_id":"a533c42a-2054-4750-b726-e7e76bf8ff21","resolution":{"observed_at":"2026-08-08T20:18:11.099207Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.082990Z","title":"Interactiongraphnet: A novel and efficient deep graph representation learning framework for accurate protein--ligand interaction predictions","venue":null,"work_id":"cc1db82b-f315-4fc4-86c2-5707aecada1e","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":42,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.864648Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:85b27cac33e1a788a2f2839a5e00f5010fd8cb2e2b63d6b460128f21d0a6a1a2","observation_id":"8cde88cd-2238-4928-ab7c-30a095cafe38","resolution":{"observed_at":"2026-08-08T20:18:11.086978Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.072362Z","title":"Jaakkola","venue":null,"work_id":"fb1a4e4d-fe9d-4af6-8e55-7608935597b0","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":43,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.868144Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7694635b46dba205b89b2d3aac249e60182e59a15d7b632efda450ff964f6c00","observation_id":"2a893688-d5a5-470e-a489-63610d6bfc8f","resolution":{"observed_at":"2026-08-08T20:18:11.075979Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.061458Z","title":"Drugpose: benchmarking 3d generative methods for early stage drug discovery","venue":null,"work_id":"c48d5a6b-d7da-434d-9232-b5c78cc03037","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":44,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.871447Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7401247d9d8633085f98ed8a4f94f0cd07a91a877368a3ae834ec3abe0fe32a2","observation_id":"afca2a63-f09d-4378-b6fb-86783ebcf206","resolution":{"observed_at":"2026-08-08T20:18:11.065188Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.874810Z","title":"Highly accurate protein structure prediction with alphafold","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":45,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.874810Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:95827eca1658fee4b176b50a7c16a3eaf81f307173e7e526a3557612920e69fd","observation_id":"2363a87c-da66-4015-9263-667b839ba20b","resolution":{"observed_at":"2026-08-08T20:18:09.874810Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.878290Z","title":"On large-batch training for deep learning: Generalization gap and sharp minima","venue":null,"work_id":null,"year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":46,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.878290Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7421b563baa766b546089a22638830fa559000651e4aa290e1f81bb18504127a","observation_id":"9796e93c-da49-4847-87e6-33ed677c9f1c","resolution":{"observed_at":"2026-08-08T20:18:09.878290Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.037137Z","title":"Lessons learned in empirical scoring with smina from the csar 2011 benchmarking exercise","venue":null,"work_id":"9b1cef30-cd20-41aa-8e4a-4a7bca2c814d","year":2011},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":47,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.881834Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b87e63c7d64c058c33dff1248da764559f25949f88894339b055e61383a147e9","observation_id":"26915f8d-e22a-4d62-872b-a4582757d782","resolution":{"observed_at":"2026-08-08T20:18:11.041335Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.025209Z","title":"Drug discovery with dynamic goal-aware fragments","venue":null,"work_id":"b190d5d0-bc33-4659-aef7-8d9d51c4a460","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":48,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.885478Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4ae0dfc7d01c62a78ac410220894c24cbeaa25a3599e2bc80eae322ba7bdaaae","observation_id":"80a50417-4fce-486f-9303-3b0ea3364f69","resolution":{"observed_at":"2026-08-08T20:18:11.029473Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.888887Z","title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":49,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.888887Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:63db7f4cf834991948e2fee07fa47b3e8578213929b3453a58093661842a0a25","observation_id":"f3ee613f-7cfd-4405-89dc-2818fe8e34b8","resolution":{"observed_at":"2026-08-08T20:18:09.888887Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:11.005890Z","title":"Multi-objective reinforcement learning: A comprehensive overview","venue":null,"work_id":"92a5f080-cd0c-4b55-af7e-7d971fd5d1d8","year":2014},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":50,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.892177Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:0da8b51037cdd0e6cf6c1499a26584c7cf29ab939dc62b816889e908f71acaa5","observation_id":"5871955d-c352-4df3-a203-3ec3ea0e425c","resolution":{"observed_at":"2026-08-08T20:18:11.009705Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.993693Z","title":"Generating 3d molecules for target protein binding","venue":null,"work_id":"4933ec77-c23e-4e0c-ab8d-6cd886f833e7","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":51,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.895610Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f605f4daa560df68c2edbbe63ae85847d033cb318e3fb8ce447d5da71560546e","observation_id":"2116e0f1-1dc4-4e7c-be56-7e2ad40b0c51","resolution":{"observed_at":"2026-08-08T20:18:10.998144Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.981817Z","title":"Forging the basis for developing protein--ligand interaction scoring functions","venue":null,"work_id":"4b164277-6136-48aa-a00d-c7a9c9b5f8c7","year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":52,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.899043Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:2ca24b399a7a22972dfcf65fc372217211f95756ad3d7d554574747ad54b7c8f","observation_id":"c2f03439-4642-47b2-a3e4-2c92c6cd4747","resolution":{"observed_at":"2026-08-08T20:18:10.985874Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.969797Z","title":"Zero-shot 3d drug design by sketching and generating","venue":null,"work_id":"dc894bb9-afb2-4852-9a41-cc64cd7e1b73","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":53,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.902398Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4e48fc98a389e1c6fb48ff69ff4781182da3b9a30f114c870296e96f98ea2947","observation_id":"361f66e3-370a-476d-b533-8c41f2b90f5d","resolution":{"observed_at":"2026-08-08T20:18:10.973857Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.905762Z","title":"Decoupled weight decay regularization","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":54,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.905762Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:6f3b6daebb077abad940c4754f0b85f619957fa842b4063093c4775af1eaf0dc","observation_id":"82c39348-c42c-4a7f-8cf1-910c3e19d8f8","resolution":{"observed_at":"2026-08-08T20:18:09.905762Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.949320Z","title":"Tankbind: Trigonometry-aware neural networks for drug-protein binding structure prediction","venue":null,"work_id":"450099da-fc40-4c85-a179-a6531c251b2c","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":55,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.909234Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:0ff855a4ccb71415fc8d3cefab2141f07b31831c81b5430f2942694db40a80f7","observation_id":"fdfef723-b094-407e-a6b9-e8bc5a24395d","resolution":{"observed_at":"2026-08-08T20:18:10.953705Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.936591Z","title":"A 3d generative model for structure-based drug design","venue":null,"work_id":"852f2544-d15b-4e4c-be8c-93c3ad82ed3f","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":56,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.913235Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:24d9d61042267efe41e558227fe61ac6912d7914d8ce7f771bfeca37e4baf2f2","observation_id":"6c3db5b4-55b4-445c-9344-397370be813a","resolution":{"observed_at":"2026-08-08T20:18:10.940536Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.924488Z","title":"Artificial intelligence in drug discovery and development","venue":null,"work_id":"6ec65cd5-bc98-48c5-b6f6-a4e63b20051a","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":57,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.916506Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:518be0edfb17e82348c2d8060e5fc21a2014ceb34a115c39c88f377d66c95e9e","observation_id":"9c57cf47-f145-4284-874a-fa6356791452","resolution":{"observed_at":"2026-08-08T20:18:10.928459Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.912555Z","title":"A geometric deep learning approach to predict binding conformations of bioactive molecules","venue":null,"work_id":"c1b7c8cc-2fdd-4274-86eb-fc66fa83411c","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":58,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.919911Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f277dd47df549b6a0f7129cac0388d6426119532c342033634c143a3704439d2","observation_id":"3007bfd4-5740-42d0-b114-d49ef95813bd","resolution":{"observed_at":"2026-08-08T20:18:10.916486Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":"2405.14108","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.384141Z","title":"Deep learning for protein-ligand docking: Are we there yet? arXiv preprint arXiv:2405.14108, 2024","venue":null,"work_id":"58dbb235-75ac-4b27-9642-2ba4b6c7549b","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":59,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.923607Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fb09a15a8f0fcf6f86f8c8349286a12c9ba713622e3fe1dfdd69cf965738713d","observation_id":"6a5def1d-2141-46cb-bfea-6c068a843d1e","resolution":{"observed_at":"2026-08-08T20:18:10.389782Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.900850Z","title":"Autodock4 and autodocktools4: Automated docking with selective receptor flexibility","venue":null,"work_id":"534e5a8d-fa4a-4b30-ab48-8229fecc43ee","year":2009},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":60,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.927002Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9ec597b25d1cc186f90e0684e0ac2a3f4dd446b32c3fea8734f6f043a3954360","observation_id":"66863145-1fb1-4bd3-b8ed-6b7302c1e708","resolution":{"observed_at":"2026-08-08T20:18:10.904723Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.930653Z","title":"Molecular de-novo design through deep reinforcement learning","venue":null,"work_id":null,"year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":61,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.930653Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:211d9dc3a550588c016281d588d96e06c69509d09be85edcbf4779162932dc46","observation_id":"76b636e5-f07a-4e9d-b209-4da6de6850b7","resolution":{"observed_at":"2026-08-08T20:18:09.930653Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.880252Z","title":"Caught between a rock and a hard place: current challenges in structure-based drug design","venue":null,"work_id":"3698ff5e-71a2-44fe-9147-7dcdb85411a6","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":62,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.934017Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fd95be5353959326deebbc51ae6ff6c5321396647d7954d893fd9072ec3d2698","observation_id":"e475b478-ab33-4880-8879-9bffdcfb3ca1","resolution":{"observed_at":"2026-08-08T20:18:10.884189Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.867854Z","title":"Fabind: Fast and accurate protein-ligand binding","venue":null,"work_id":"ee028845-3173-43e5-b7f6-e101a69d69cb","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":63,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.937507Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:13d64117720d4c3b0685c5fcf0e9eff413bc4de4b9ca5e1ab52e5c23983363f2","observation_id":"509945b7-e991-4fc6-ba56-c718568433ce","resolution":{"observed_at":"2026-08-08T20:18:10.872277Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.855653Z","title":"Pocket2mol: Efficient molecular sampling based on 3d protein pockets","venue":null,"work_id":"845d7931-3509-4ddd-8072-ef35e3ae5fcf","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":64,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.940940Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:8c31d04d39730c6902709502f94837492bd0d39d39a609dfa9644a21548f6283","observation_id":"2689b3dd-3284-482a-8f69-65a729c78977","resolution":{"observed_at":"2026-08-08T20:18:10.859832Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.843835Z","title":"Dive into deep learning: Tools for engagement","venue":null,"work_id":"7e2c8112-9976-4652-89e0-ecba6c5bd272","year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":65,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.944182Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:8001bdd145f260977e4686b0e7aed7d795af7ac6552b85393f84493aa5e86711","observation_id":"6e74f67a-9406-405b-a7ab-e5b8baa79e57","resolution":{"observed_at":"2026-08-08T20:18:10.847934Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.831954Z","title":"Vinardo: A scoring function based on autodock vina improves scoring, docking, and virtual screening","venue":null,"work_id":"6be6c851-7364-45ce-b906-977230bc781e","year":2016},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":66,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.947483Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:957adb4c4dde2c81b41f38f5040b577f2d96237375703c5f23c6718b4a744958","observation_id":"87829da1-a78d-4ce6-9617-9e0d1451b83c","resolution":{"observed_at":"2026-08-08T20:18:10.836064Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.950978Z","title":"Language models are unsupervised multitask learners","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":67,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.950978Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:f7b5f6bf845b996ca18a63d75f13d1646a69fda4bbf303944dfda68747a5fdac","observation_id":"679c2ab1-d598-46cb-b2c0-0a42de13ba4d","resolution":{"observed_at":"2026-08-08T20:18:09.950978Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:09.954278Z","title":"Generating 3d molecules conditional on receptor binding sites with deep generative models","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":68,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.954278Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:73b99d966ff47f967469fd713b626700b2f131230f49d396a64f30348fa1efb7","observation_id":"70c3b1be-46ef-4ef3-a3c7-37c772cb17c1","resolution":{"observed_at":"2026-08-08T20:18:09.954278Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2210.13695","last_updated":"2024-09-23T19:31:01Z","snapshot_observed_at":"2026-08-08T05:39:11.029974Z","submitted_at":"2022-10-24T15:51:21Z","title":"Structure-based Drug Design with Equivariant Diffusion Models","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2210.13695","snapshot_observed_at":"2026-08-08T20:18:09.958049Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":69,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.958049Z"},"links":{"cited_paper":"/paper/2210.13695","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:edfcbac68803c88f83921c93292868c39840e2d82b6747ba22b18919a7b5b677","observation_id":"346c372c-bac4-46a2-83e9-800f59cf6b2e","resolution":{"observed_at":"2026-08-08T20:18:09.958049Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.803693Z","title":"Molecular transformer: a model for uncertainty-calibrated chemical reaction prediction","venue":null,"work_id":"36835da0-cdea-4257-b465-aa420f53bf4f","year":2019},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":70,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.961908Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:09c13e5209855d81612082a08583e6dfa66b55272e97510bcb62eebe22c2c7cd","observation_id":"083e76c6-cee7-43ef-a572-734c0663562f","resolution":{"observed_at":"2026-08-08T20:18:10.807910Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.792076Z","title":"Generating focused molecule libraries for drug discovery with recurrent neural networks","venue":null,"work_id":"3506e3f4-1498-40d8-825d-3dc8db59fcaf","year":2018},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":71,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.965288Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:3f39972b2ee2f0764ec248a0a8a2b212a85a408e3c2eae72e56daa1f30e11955","observation_id":"8fb21802-63b4-4198-be83-2c971f26bf4b","resolution":{"observed_at":"2026-08-08T20:18:10.795986Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.780230Z","title":"Reinforcement learning for molecular design guided by quantum mechanics","venue":null,"work_id":"c1e04c99-8a6b-405a-9563-98a8857b909d","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":72,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.968510Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:44edf5256dacf3995635d71c475f4645adb32e1c73e1bd13abd4a47c49b89030","observation_id":"8bf760f4-8384-4a1e-ab5f-1f729ee2e336","resolution":{"observed_at":"2026-08-08T20:18:10.784295Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.768680Z","title":"Autogrow4: an open-source genetic algorithm for de novo drug design and lead optimization","venue":null,"work_id":"4674081c-5a55-493f-b59f-c13534cb92f0","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":73,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.971671Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:4f3d28f981c5dbf9e057add94d9a40faa252911bb3dc16ca325c78e326f70a0d","observation_id":"264d2119-d088-46b9-bbf5-42403ee00777","resolution":{"observed_at":"2026-08-08T20:18:10.772677Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.758104Z","title":"Equibind: Geometric deep learning for drug binding structure prediction","venue":null,"work_id":"b07fbd31-6acd-4e5d-85fe-b1918b905da0","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":74,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.975113Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:e1b47cdcd7962a399903d2a3854c0b3fb750b4fd5b0280f00110d7e5c411a6e0","observation_id":"bedc8dbb-5bbe-445c-8453-608ddb6f3e95","resolution":{"observed_at":"2026-08-08T20:18:10.761845Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.637027Z","title":"Comparative assessment of scoring functions: the casf-2016 update","venue":null,"work_id":"da64dca0-025b-4e5d-8040-67e21d49b71d","year":2016},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":75,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.979039Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:027ed412b31086a0188c607bfa19ec2bbae2932f78a5b62af71b7232a9033d47","observation_id":"a4bec532-85d6-4ccf-9691-4faa636b3420","resolution":{"observed_at":"2026-08-08T20:18:10.751038Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2303.17615","last_updated":"2024-01-30T21:09:48Z","snapshot_observed_at":"2026-08-09T05:02:17.368406Z","submitted_at":"2023-03-30T07:40:50Z","title":"Utilizing Reinforcement Learning for de novo Drug Design","version":2},"cited_work":{"arxiv_id":"2303.17615","doi":null,"metadata_source":"pith","pith_arxiv_id":"2303.17615","snapshot_observed_at":"2026-08-08T20:18:10.170252Z","title":"Utilizing Reinforcement Learning for de novo Drug Design","venue":"q-bio.BM","work_id":"0c8efddd-e310-42c2-b115-6e58336429c0","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":76,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.982465Z"},"links":{"cited_paper":"/paper/2303.17615","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:e45a501a862142ac21ba3e1e76132c6fa8d807374e63fe1aa7901b29d1a1d23c","observation_id":"d323661d-bb53-43a3-9a4c-496702d57ffa","resolution":{"observed_at":"2026-08-08T20:18:10.174588Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.626865Z","title":"Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","venue":null,"work_id":"33ad1a6d-05ed-4229-b423-9c4f92df9f95","year":2010},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":77,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.986290Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:ca94ea92329a1e0c5221d51e8f679ec5618a07d8f9c9a7f420f50e64d52b6a65","observation_id":"0575cba2-2027-4bbd-ab31-f790cb65da9f","resolution":{"observed_at":"2026-08-08T20:18:10.630691Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.616682Z","title":"Structure-based drug design: aiming for a perfect fit","venue":null,"work_id":"4eb7d928-5d6a-4854-baa6-a4e5881914c6","year":2017},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":78,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.989810Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a3bb879c5b520088590ac1fa808c7bbac2a2c99e8fa60aeb3a4aa51ba210a19e","observation_id":"aeea9409-18e7-4af4-8dbe-bae6659c9b66","resolution":{"observed_at":"2026-08-08T20:18:10.620494Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.604499Z","title":"Structure-based, deep-learning models for protein-ligand binding affinity prediction","venue":null,"work_id":"1ace244f-cc5a-44e5-8cd1-1468de494920","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":79,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.993216Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:9ca321686403292bf0ded6e36ba981b9c85d87fe0d63fd2f810355a169927634","observation_id":"8282e32b-1ac5-4642-98ba-0bd70f49ce4f","resolution":{"observed_at":"2026-08-08T20:18:10.608387Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2407.07930","last_updated":"2024-08-19T07:32:25Z","snapshot_observed_at":"2026-07-06T18:44:24.873040Z","submitted_at":"2024-07-10T07:22:15Z","title":"Token-Mol 1.0: Tokenized drug design with large language model","version":2},"cited_work":{"arxiv_id":"2407.07930","doi":null,"metadata_source":"pith","pith_arxiv_id":"2407.07930","snapshot_observed_at":"2026-08-08T20:18:10.155644Z","title":"Token-Mol 1.0: Tokenized drug design with large language model","venue":"q-bio.BM","work_id":"dad34a0a-b5e2-4fd6-86ab-1b43c500ff65","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":80,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.996703Z"},"links":{"cited_paper":"/paper/2407.07930","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:b7f3903cffafc0de7fa105201336524a57dce10dd3c4c213ebb9ca8b35544148","observation_id":"a687610c-4b0e-4367-a834-54241b5d3cc6","resolution":{"observed_at":"2026-08-08T20:18:10.159700Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.593365Z","title":"Property-aware relation networks for few-shot molecular property prediction","venue":null,"work_id":"21deebdd-220a-4df5-99c0-2ee53a43c0e1","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":81,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.000112Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fd1670d65024ee0c9dbd51e3cbe00e6f69b53b9ea9ddd1a426ec56a16038007f","observation_id":"c6159adf-f65a-4b11-a9af-1534ddfc9508","resolution":{"observed_at":"2026-08-08T20:18:10.597186Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.581601Z","title":"A compact review of molecular property prediction with graph neural networks","venue":null,"work_id":"73e4e931-f27f-4b8b-bbf2-c2439d8952c7","year":2020},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":82,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.003437Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:1dde3d79bf0a3b44c225d46b7c8050e88b0b5095f42176e3dca91131834c7cdc","observation_id":"c2f57260-5437-4b27-9d2c-a8c8a31433bc","resolution":{"observed_at":"2026-08-08T20:18:10.585914Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.569375Z","title":"A systematic survey of chemical pre-trained models","venue":null,"work_id":"2e6848f1-2ade-444e-ae6c-83f016447a2f","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":83,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.007159Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:148b20ee1a876408cb35e5cd30c431b99a8d4bdb4ac87b2932ad7561c8fe26cd","observation_id":"ffb26cbd-246e-41ca-8421-eab55dda90d3","resolution":{"observed_at":"2026-08-08T20:18:10.573497Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.558677Z","title":"Protein--ligand docking in the machine-learning era","venue":null,"work_id":"ae91b17d-ac0a-46b1-b270-3e527f3695e9","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":84,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.010547Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:89699fe629f3719988fdb2633831abfc599474b90e983c329ae27f910a9537eb","observation_id":"4c70bd3f-93b0-4375-a015-94504c190966","resolution":{"observed_at":"2026-08-08T20:18:10.562494Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.548507Z","title":"Deep molecular representation learning via fusing physical and chemical information","venue":null,"work_id":"ee250599-d8f4-4488-9e08-42ce92b20eca","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":85,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.013813Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:fc918da702074593120879e3c354e393585ab19e385f46e33cb1d3f2c562ae1a","observation_id":"04b8d631-320f-4842-af32-b6cbd7e112d6","resolution":{"observed_at":"2026-08-08T20:18:10.552259Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.538401Z","title":"Hit and lead discovery with explorative rl and fragment-based molecule generation","venue":null,"work_id":"a581fc0d-b55f-4129-a27f-9bf658481119","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":86,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.017199Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:13935ccc41ea1907d1b8d931e06b4e82639d94fce86ec8bb32660f7a693bbf3f","observation_id":"946711d7-4f20-48e8-8f32-50cb6888ed0a","resolution":{"observed_at":"2026-08-08T20:18:10.542025Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.527507Z","title":"Graph convolutional policy network for goal-directed molecular graph generation","venue":null,"work_id":"f9939f94-c8fd-479f-b1dc-3f58e672bc47","year":2018},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":87,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.021340Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:68408c46fe22dae97d09110dca64bbb1712b95e7d05ddbbe563e59052b6e790d","observation_id":"abbb046f-71c2-487e-92ed-cc2607b874df","resolution":{"observed_at":"2026-08-08T20:18:10.531423Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.515994Z","title":"E3bind: An end-to-end equivariant network for protein-ligand docking","venue":null,"work_id":"71b1c7b1-729e-414f-8f92-ebd656974c07","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":88,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.025782Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a0893410b8816514716ac7d607beac950e21201ca74f02e0eb3597b8e3cc2ec1","observation_id":"f8a7be81-e268-4b2f-9f01-068283e9c104","resolution":{"observed_at":"2026-08-08T20:18:10.519706Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.504808Z","title":"Motif-based graph self-supervised learning for molecular property prediction","venue":null,"work_id":"908b12f8-2191-460a-bf6a-24282179fe28","year":2021},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":89,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.029168Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:7781856f1f8f2f7b49dfdfba5ae85ad8d00808bfb5fe96b08ace8f29f0721838","observation_id":"38aed36c-c43d-47be-b181-4362b8ea15c9","resolution":{"observed_at":"2026-08-08T20:18:10.508510Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2306.11768","last_updated":"2024-11-16T02:51:56Z","snapshot_observed_at":"2026-08-07T07:32:13.836485Z","submitted_at":"2023-06-20T14:21:58Z","title":"Geometric Deep Learning for Structure-Based Drug Design: A Survey","version":6},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2306.11768","snapshot_observed_at":"2026-08-08T20:18:10.033108Z","title":"A systematic survey in geometric deep learning for structure-based drug design","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":90,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.033108Z"},"links":{"cited_paper":"/paper/2306.11768","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:bdd1610d1ef49a2875d87a4d86095024bad2f06dfe1ac1753ee76d68d8689229","observation_id":"3fbfe4f9-2f6c-4fea-a03e-c731182e6481","resolution":{"observed_at":"2026-08-08T20:18:10.033108Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.493919Z","title":"A brief review of protein--ligand interaction prediction","venue":null,"work_id":"f01fbf71-ee61-4021-9072-4c1e5bae5531","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":91,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.037090Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:78c1f951b2345a349e731bcec44b15813866af4a31e6390118ebbe37eaaad5de","observation_id":"a153ff62-f977-41ae-8177-a77c7469c97f","resolution":{"observed_at":"2026-08-08T20:18:10.497904Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2406.03403","last_updated":"2024-06-04T15:37:14Z","snapshot_observed_at":"2026-08-08T20:48:05.445012Z","submitted_at":"2024-06-04T15:37:14Z","title":"Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?","version":1},"cited_work":{"arxiv_id":"2406.03403","doi":null,"metadata_source":"pith","pith_arxiv_id":"2406.03403","snapshot_observed_at":"2026-08-08T20:18:10.130525Z","title":"Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?","venue":"cs.LG","work_id":"b0410432-ce9b-436a-a78d-b85f480cb448","year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":92,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.040546Z"},"links":{"cited_paper":"/paper/2406.03403","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:55fb5d45aa47102b90b1d17a1076817f9e549e6722096da7fb0292fe0e90babc","observation_id":"2743eae0-ad14-4ccf-9056-e858260bc2a7","resolution":{"observed_at":"2026-08-08T20:18:10.134374Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.483004Z","title":"Uni-mol: A universal 3d molecular representation learning framework","venue":null,"work_id":"87937cf1-7516-454d-9a48-33065f795949","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":94,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.048412Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:24219d8e5a149efab16e566b06744a4e3d2506ffa3cabc158b1a23db00c1f8a1","observation_id":"5312db31-4ac8-4ba0-ace7-8ff9963bfc64","resolution":{"observed_at":"2026-08-08T20:18:10.486834Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2302.07061","last_updated":"2023-03-27T14:15:37Z","snapshot_observed_at":"2026-07-06T14:51:40.948938Z","submitted_at":"2023-02-14T14:21:26Z","title":"Do Deep Learning Methods Really Perform Better in Molecular Conformation Generation?","version":2},"cited_work":{"arxiv_id":"2302.07061","doi":null,"metadata_source":"pith","pith_arxiv_id":"2302.07061","snapshot_observed_at":"2026-08-08T20:18:10.100544Z","title":"Do Deep Learning Methods Really Perform Better in Molecular Conformation Generation?","venue":"cs.CE","work_id":"b11d2e21-d53a-48fc-9a66-707bbc0d2fbc","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":95,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.051779Z"},"links":{"cited_paper":"/paper/2302.07061","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:baf7c0e94064eb04ce7cc8102346c84cdbbc7ecdce5b2dc34f05b95670d28bd6","observation_id":"bf3fe4c2-9dd4-4934-bc0c-de25d23ec97e","resolution":{"observed_at":"2026-08-08T20:18:10.107568Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.472111Z","title":"Unified 2d and 3d pre-training of molecular representations","venue":null,"work_id":"3e81b2d9-99c0-4f58-a169-31702801aad5","year":2022},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":96,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.055502Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d4e18d671b45befe2cbb085547cbfa09365877bc6cbc8a1709bca3839b4e1bd8","observation_id":"ba3de2d3-1021-47b8-bbe8-9ea6c81fadb7","resolution":{"observed_at":"2026-08-08T20:18:10.475868Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.059028Z","title":"@esa (Ref","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":97,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.059028Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:c2d70c79c60fdd9c65578259e71998a075696d596eb881bd4b9ac58238f83911","observation_id":"addbffc9-7b7e-440d-9048-d8ba6c465dbd","resolution":{"observed_at":"2026-08-08T20:18:10.059028Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-08T20:18:10.063098Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":98,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.063098Z"},"links":{"citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:c69ade3088ecfff63f41482fe2f975e97c849996b905dca0887a1a551ae11df8","observation_id":"be63a7fa-2cf3-4ab9-891c-85ba162f80ec","resolution":{"observed_at":"2026-08-08T20:18:10.063098Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2406.03686","last_updated":"2024-06-06T02:10:50Z","snapshot_observed_at":"2026-07-06T18:26:15.151211Z","submitted_at":"2024-06-06T02:10:50Z","title":"BindGPT: A Scalable Framework for 3D Molecular Design via Language Modeling and Reinforcement Learning","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2406.03686","snapshot_observed_at":"2026-08-08T20:18:10.067022Z","title":"BERT : Pre-training of Deep Bidirectional Transformers for Language Understanding","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":99,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:10.067022Z"},"links":{"cited_paper":"/paper/2406.03686","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:a8b5ee6980f1dca8b8438851e0f72552a61b0d8d15550f54fd8af5aa4b6c2dfd","observation_id":"1bb5577f-c904-41b3-9254-4f8905188f85","resolution":{"observed_at":"2026-08-08T20:18:10.067022Z","resolver_source":null,"status":"malformed_identifier"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","latest_version":1,"primary_category":"cs.CE","snapshot_observed_at":"2026-08-09T14:07:03.931371Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery"},"reference_resolution":{"displayed":98,"state_counts":{"malformed_identifier":1,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":35,"verified_exact":5,"verified_fuzzy":57},"total_outbound_references":98},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"thesis":"As of 10 August 2026, this Paper Citation Record lists 98 of 98 outbound references and 2 inbound Pith citation observations for arXiv:2502.05107."}